Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 7 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Moderna's New RSV Vaccine Undercuts the Promise of mRNA
Bloomberg via Yahoo Finance· 6 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 4 hours agoMeanwhile, the second and third largest shareholders, hold 10% and 6.6%, of the shares outstanding,...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 days agos first-quarter 2024 financial results and business updates. You can access the press release issued this morning as well as the slides that we'll be...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 2 days agoWith a valuation of US$47 billion (~A$71 billion), Moderna aims to leverage AI to automate functions...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 7 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 7 days agoThose products could range from RSV vaccines to individualized cancer treatments, which will help...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around $0.3bn in net sales for the first half of the...
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3...
Morningstar· 1 day agoFN Media Group News Commentary - There is much activity in finding better ways in mitigating muscle loss for the cancer patients… many clinical studies are looking for elite performance nutritional ...
Biotech’s bind over China bill
Politico· 6 days agoCEO Stéphane Bancel touted the vaccine candidate’s safety and efficacy data as “stronger” than competitors’ though another company official noted Moderna ...
